• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: Director Thompson Laura K was granted 299 units of Restricted Stock Units, increasing direct ownership by 7% to 4,337 units (SEC Form 4)

    4/28/25 4:05:09 PM ET
    $PH
    Metal Fabrications
    Industrials
    Get the next $PH alert in real time by email
    SEC FORM 4/A SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Thompson Laura K

    (Last) (First) (Middle)
    6035 PARKLAND BOULEVARD

    (Street)
    CLEVELAND OH 44124

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Parker-Hannifin Corp [ PH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    10/23/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    10/25/2024
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Restricted Stock Units 10/23/2024 A 299(1) A $0 4,337(2) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Award of Restricted Stock Units on October 23, 2024 will vest on the later of (a) one year from the grant date; or (b) on the date of our next Annual Shareholders Meeting.
    2. Includes 5 shares acquired as a dividend reinvestment feature under the Parker-Hannifin Corporation 2023 Omnibus Stock Incentive Plan.
    Remarks:
    Exhibit List: Exhibit 24 Power of Attorney: On October 25, 2024, the reporting person filed a Form 4 which inadvertently failed to include an updated Power of Attorney. The sole purpose of this Amendment is to file the Power of Attorney filed herewith as Exhibit 24. The transaction included on this report was previously included on the Form 4 filed by the reporting person on October 25, 2024 and has not been revised.
    /s/ Stephanie R. Breitenbach, Attorney-in-Fact 04/28/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PH

    DatePrice TargetRatingAnalyst
    6/5/2025$700.00Equal-Weight
    Morgan Stanley
    4/3/2025Outperform → Peer Perform
    Wolfe Research
    2/7/2025$795.00Buy
    Citigroup
    12/12/2024$786.00Peer Perform → Outperform
    Wolfe Research
    11/18/2024$691.00Buy → Hold
    Stifel
    11/13/2024$842.00Buy
    UBS
    6/28/2024$610.00Outperform
    Raymond James
    5/28/2024$550.00 → $650.00Neutral → Buy
    Mizuho
    More analyst ratings